Sydnexis

(No Reviews)
445 Marine View Ave Suite 295, Del Mar, CA 92014, USA

Sydnexis is located in San Diego County of California state. On the street of Marine View Avenue and street number is 445. To communicate or ask something with the place, the Phone number is (858) 925-6172. You can get more information from their website.
The coordinates that you can use in navigation applications to get to find Sydnexis quickly are 32.9901531 ,-117.2550731

Contact and Address

Address: 445 Marine View Ave Suite 295, Del Mar, CA 92014, USA
Postal code: 92014
Phone: (858) 925-6172
Website: http://sydnexis.com/

Location & routing

Get Directions

Reviews

There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Sydnexis, use the form below and your opinion, advice or comment will appear in this space.

Write a Review


Sydnexis On the Web

Sydnexis

445 Marine View Avenue, Suite 295 Del Mar, Ca 92014. 858-925-6172 info@sydnexis.com.


Scott E Oross | Sydnexis, Inc. in its $35 million Series A financing

Partner, Corporate Department. San Diego. T 1(858) 458-3032.


Sydnexis Company Profile: Valuation & Investors | PitchBook

Information on valuation, funding, cap tables, investors, and executives for Sydnexis. Use the PitchBook Platform to explore the full profile. To explore Sydnexis's full profile, request a free trial. Sydnexis Valuation and Funding. Deal Type.


Biocom LifeLines - Spring 2018 by Biocom - Issuu

Sunesis Pharmaceuticals Sun Genomics Sunovion Pharmaceuticals Surrozen Switch Bio Sydnexis Synova Life Sciences Synthetic Genomics Takeda Biocom LifeLines Spring 2018. 37. 10996 Torreyana Rd, Suite 200 San Diego, CA 92121-3021 www.Biocom.org 858.455.0300 Please send a...


Find Paid Research Studies in Raleigh, North Carolina

Conditions: Nearsightedness; Near Sightedness; Near-sightedness Interventions: Drug: SYD-101 Dose 1; Drug: SYD-101 Dose 2; Drug: Vehicle Sponsor: Sydnexis, Inc. Recruiting. A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata.